Overview Of Bladder Cancer
Bladder cancer is one of the most common cancers, affecting approximately 68,000 adults in the United States each year. Bladder cancer occurs in men more frequently than it does in women and usually affects older adults, though it can happen at any age.
Bladder cancer most often begins in the cells (urothelial cells) that line the inside of your bladder — the hollow, muscular organ in your lower abdomen that stores urine. Although it's most common in the bladder, this same type of cancer can occur in other parts of the urinary tract drainage system.
About seven out of every 10 bladder cancers diagnosed start out at an early stage — when bladder cancer is highly treatable. However, even early-stage bladder cancer may recur in the bladder. For this reason, people with bladder cancer typically need follow-up tests for years after treatment to look for bladder cancer that recurs or advances to a higher stage.
Symptoms Of Bladder Cancer
Bladder cancer signs and symptoms may include:
Blood in urine (hematuria)
If you have hematuria, your urine may appear bright red or cola colored. Sometimes, urine may not look any different, but blood in urine may be detected during a microscopic exam of the urine.
People with bladder cancer might also experience:
But, these symptoms often occur because of something other than bladder cancer.
Causes Of Bladder Cancer
Bladder cancer develops when cells in the bladder begin to grow abnormally. Rather than grow and divide in an orderly way, these cells develop mutations that cause them to grow out of control and not die. These abnormal cells form a tumor.
Causes of bladder cancer include:
Smoking and other tobacco use
Exposure to chemicals, especially working in a job that requires exposure to chemicals
Past radiation exposure
Chronic irritation of the lining of the bladder
Parasitic infections, especially in people who are from or have traveled to certain areas outside the United States
It's not always clear what causes bladder cancer, and some people with bladder cancer have no obvious risk factors. Investigations are currently being conducted regarding the link to Zantac Bladder Cancer.
Bladder Cancer And Zantac
Brand-name Zantac products are commonly used in the United States and worldwide to treat issues such as heartburn, acid reflux, and ulcers.
Recent concerns have emerged about the safety of Zantac, however, in response to alarming test results out of the laboratory of online pharmacy, Valisure. These test results showed unsafe levels of a carcinogenic (cancerous) chemical known as NDMA in their tested Zantac products.
One of the types of cancer linked to overexposure to NDMA is bladder cancer.
Many people who have taken Zantac regularly, or have lost a loved one to cancer after using Zantac products, are now suing Zantac drugmakers for failing to disclose the potential link between use of their products and various cancers.
How To Know If Zantac Caused Your Bladder Cancer
Zantac is a brand name for the generic drug, ranitidine. Not all ranitidine products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.
If you are concerned about your risk for developing bladder cancer after taking Zantac, or wish to know if Zantac caused your bladder cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your bladder cancer through careful consideration of your medical history and Zantac use.
At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Zantac and ranitidine products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Zantac is currently ongoing.
What To Do If You Think Zantac Caused Your Bladder Cancer
If you were diagnosed with kidney cancer after taking Zantac regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Zantac or ranitidine products.
The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.
In the context of recent Zantac lawsuits, the negligence of named defendants (Zantac drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.
The types of Zantac cancer lawsuits that have been filed include:
product liability (defective drug) lawsuits
personal injury lawsuits
wrongful death lawsuits
Several plaintiffs who have taken legal action against Zantac drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Zantac through their regular use of the drugs.
If you’ve been diagnosed with bladder cancer after taking Zantac and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a zantac lawsuit for bladder cancer.
You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.